DK1563071T3 - Protein, som er specifikt for pankreatiske beta-celler fra Langerhans-öer, og anvendelser deraf - Google Patents
Protein, som er specifikt for pankreatiske beta-celler fra Langerhans-öer, og anvendelser derafInfo
- Publication number
- DK1563071T3 DK1563071T3 DK03786019T DK03786019T DK1563071T3 DK 1563071 T3 DK1563071 T3 DK 1563071T3 DK 03786019 T DK03786019 T DK 03786019T DK 03786019 T DK03786019 T DK 03786019T DK 1563071 T3 DK1563071 T3 DK 1563071T3
- Authority
- DK
- Denmark
- Prior art keywords
- cells
- sequence
- protein
- nucleic acid
- iia
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 8
- 102000004169 proteins and genes Human genes 0.000 title abstract 6
- 210000004153 islets of langerhan Anatomy 0.000 title abstract 3
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 230000004075 alteration Effects 0.000 abstract 2
- 230000003321 amplification Effects 0.000 abstract 2
- 230000003178 anti-diabetic effect Effects 0.000 abstract 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 238000000018 DNA microarray Methods 0.000 abstract 1
- 108091060211 Expressed sequence tag Proteins 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 108090000702 Zinc Transporter 8 Proteins 0.000 abstract 1
- 102000004248 Zinc Transporter 8 Human genes 0.000 abstract 1
- 108091006550 Zinc transporters Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 239000013599 cloning vector Substances 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000028023 exocytosis Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 230000035800 maturation Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 abstract 1
- 238000013518 transcription Methods 0.000 abstract 1
- 230000035897 transcription Effects 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0214374A FR2847263B1 (fr) | 2002-11-18 | 2002-11-18 | Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans |
| PCT/FR2003/003413 WO2004046355A2 (fr) | 2002-11-18 | 2003-11-18 | Proteine specifique des cellules pancreatiques beta des ilots de langerhans et ses applications. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1563071T3 true DK1563071T3 (da) | 2009-02-02 |
Family
ID=32187667
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03786019T DK1563071T3 (da) | 2002-11-18 | 2003-11-18 | Protein, som er specifikt for pankreatiske beta-celler fra Langerhans-öer, og anvendelser deraf |
| DK08002520.8T DK1925667T3 (da) | 2002-11-18 | 2003-11-18 | Protein, som er specifikt for de pankreatiske beta-celler i de langerhanske øer, og dets anvendelser |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08002520.8T DK1925667T3 (da) | 2002-11-18 | 2003-11-18 | Protein, som er specifikt for de pankreatiske beta-celler i de langerhanske øer, og dets anvendelser |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7851164B2 (ja) |
| EP (3) | EP2239272B1 (ja) |
| JP (2) | JP4498144B2 (ja) |
| CN (2) | CN1738900B (ja) |
| AT (2) | ATE408689T1 (ja) |
| AU (1) | AU2003295025B2 (ja) |
| CA (1) | CA2506331C (ja) |
| DE (2) | DE60323664D1 (ja) |
| DK (2) | DK1563071T3 (ja) |
| ES (3) | ES2314268T3 (ja) |
| FR (1) | FR2847263B1 (ja) |
| WO (1) | WO2004046355A2 (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008065544A2 (en) * | 2006-09-11 | 2008-06-05 | Mcgill University | Genetic predictors of risk for type 2 diabetes mellitus |
| WO2008083331A2 (en) * | 2006-12-29 | 2008-07-10 | The Regents Of The University Of Colorado | Diagnostic and therapeutic target for autoimmune diseases and uses thereof |
| WO2008096009A2 (en) * | 2007-02-09 | 2008-08-14 | Mellitech | Polymorphism in the slc30a8 gene |
| US8425878B2 (en) | 2008-02-14 | 2013-04-23 | Universite Libre De Bruxelles | Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells |
| US20110286977A1 (en) * | 2008-09-30 | 2011-11-24 | Novo Nordisk A/S | G6PC2-Encoded Beta Cell Surface Tags |
| US20120070847A1 (en) | 2008-11-07 | 2012-03-22 | Jan Jensen | Method For Detecting And Purifying Pancreatic Beta Cells |
| KR101802536B1 (ko) * | 2009-08-05 | 2017-11-28 | 큐알엔에이, 인크. | 인슐린 유전자 (ｉｎｓ)에 대한 자연 안티센스 전사체의 저해에 의한 인슐린 유전자 (ｉｎｓ) 관련된 질환의 치료 |
| EP2537859A1 (en) | 2011-06-23 | 2012-12-26 | Université de Mons | Molecules specifically binding pancreatic beta cells biomarkers |
| ES2684976T3 (es) | 2012-04-13 | 2018-10-05 | Diabetomics, Inc. | Biomarcadores maternos para diabetes gestacional |
| CN104098675A (zh) * | 2013-04-03 | 2014-10-15 | 苏州偲聚生物材料有限公司 | 多肽、包含该多肽的检测器件和检测试剂盒 |
| CN104098673A (zh) * | 2013-04-03 | 2014-10-15 | 苏州偲聚生物材料有限公司 | 多肽、包含该多肽的检测器件和检测试剂盒 |
| EP3123169B1 (en) | 2014-03-26 | 2022-05-04 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Flattop (fltp) is a novel biomarker for beta cell maturation |
| GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
| GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201520603D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| WO2017189483A1 (en) | 2016-04-25 | 2017-11-02 | The Johns Hopkins University | Znt8 assays for drug development and pharmaceutical compositions |
| CN106226526A (zh) * | 2016-06-30 | 2016-12-14 | 深圳市亚辉龙生物科技股份有限公司 | 一种锌转运蛋白8抗体化学发光免疫检测试剂盒及其制备方法 |
| WO2019014044A1 (en) | 2017-07-12 | 2019-01-17 | The Johns Hopkins University | ZNT8 AUTO-ANTIGEN BASED ON PROTEOLIPOSOMES FOR THE DIAGNOSIS OF TYPE 1 DIABETES |
| CN113166241A (zh) * | 2018-08-16 | 2021-07-23 | 约翰霍普金斯大学 | 人类znt8抗体 |
| CN109734793B (zh) * | 2019-03-14 | 2022-12-02 | 深圳市药品检验研究院（深圳市医疗器械检测中心） | 一种ZnT8重组蛋白及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| NL9001083A (nl) | 1990-05-04 | 1991-12-02 | Rijksuniversiteit | Beta-cel antigeen. |
| ZA97476B (en) * | 1996-01-22 | 1998-07-21 | Res Dev Foundation | Novel methods for the characterization of compounds which stimulate STF-1 expression in pancreatic islet cells. |
| AU778155B2 (en) * | 1999-12-13 | 2004-11-18 | Scripps Research Institute, The | Markers for identification and isolation of pancreatic islet alpha and beta cell progenitors |
| US20020082207A1 (en) * | 2000-06-07 | 2002-06-27 | Hirst Shannon K. | Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| JP2004529607A (ja) * | 2000-09-15 | 2004-09-30 | キュラジェン コーポレイション | ヒトポリヌクレオチドおよびそれによってコードされるポリペプチド |
| WO2002060953A2 (en) * | 2000-12-15 | 2002-08-08 | Agensys, Inc. | Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer |
-
2002
- 2002-11-18 FR FR0214374A patent/FR2847263B1/fr not_active Expired - Fee Related
-
2003
- 2003-11-18 DE DE60323664T patent/DE60323664D1/de not_active Expired - Lifetime
- 2003-11-18 AT AT03786019T patent/ATE408689T1/de not_active IP Right Cessation
- 2003-11-18 ES ES03786019T patent/ES2314268T3/es not_active Expired - Lifetime
- 2003-11-18 EP EP10007471.5A patent/EP2239272B1/fr not_active Expired - Lifetime
- 2003-11-18 AU AU2003295025A patent/AU2003295025B2/en not_active Ceased
- 2003-11-18 WO PCT/FR2003/003413 patent/WO2004046355A2/fr active IP Right Grant
- 2003-11-18 JP JP2004552811A patent/JP4498144B2/ja not_active Expired - Fee Related
- 2003-11-18 CA CA2506331A patent/CA2506331C/fr not_active Expired - Fee Related
- 2003-11-18 EP EP08002520A patent/EP1925667B1/fr not_active Expired - Lifetime
- 2003-11-18 DK DK03786019T patent/DK1563071T3/da active
- 2003-11-18 CN CN2003801088861A patent/CN1738900B/zh not_active Expired - Fee Related
- 2003-11-18 DK DK08002520.8T patent/DK1925667T3/da active
- 2003-11-18 ES ES08002520T patent/ES2361639T3/es not_active Expired - Lifetime
- 2003-11-18 US US10/535,395 patent/US7851164B2/en not_active Expired - Fee Related
- 2003-11-18 DE DE60335676T patent/DE60335676D1/de not_active Expired - Lifetime
- 2003-11-18 ES ES10007471.5T patent/ES2454592T3/es not_active Expired - Lifetime
- 2003-11-18 AT AT08002520T patent/ATE494376T1/de not_active IP Right Cessation
- 2003-11-18 EP EP03786019A patent/EP1563071B1/fr not_active Expired - Lifetime
- 2003-11-18 CN CN2011101575572A patent/CN102250242A/zh active Pending
-
2010
- 2010-01-14 JP JP2010005852A patent/JP5202550B2/ja not_active Expired - Fee Related
- 2010-10-19 US US12/907,695 patent/US9568482B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1563071T3 (da) | Protein, som er specifikt for pankreatiske beta-celler fra Langerhans-öer, og anvendelser deraf | |
| Wei et al. | Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of type 2 diabetes | |
| US20180216084A1 (en) | Hsd17b13 variants and uses thereof | |
| JP2006506084A5 (ja) | ||
| CN101568646B (zh) | 基因扩增用引物对、含有其的基因扩增用试剂及其用途 | |
| RU2009135270A (ru) | Способы выявления воспалительного заболевания кишечника | |
| BRPI0907629A2 (pt) | enzimas e genes transportadores de açúcar termoacidofílico e termofílico de alicyclobacillus acidocaldarius e organismos relacionados e métodos | |
| CN112760324B (zh) | 一种提高家蚕产丝量的方法 | |
| EP2502994A1 (en) | Primer set for amplification of mthfr gene, mthfr gene amplification reagent comprising same, and use of same | |
| ZA200606354B (en) | Method of identifying genes which promote hybrid vigour and hybrid debility and uses thereof | |
| DK1305636T3 (da) | Screeningsmetode | |
| KR102124652B1 (ko) | 개의 불안장애 조기 예측 또는 진단용 조성물 | |
| CN106536753A (zh) | 用于确定对mek/erk抑制剂的应答性的方法 | |
| KR20200073407A (ko) | 돼지 정액의 품질 판별용 단일염기다형성(snp) 마커 및 이의 용도 | |
| US10704098B2 (en) | Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis | |
| Larsson et al. | Detection of gastrin and its messenger RNA in Zollinger-Ellison tumors by non-radioactive in situ hybridization and immunocytochemistry | |
| IL142755A0 (en) | Mutation of the parkin gene, compositions, methods and uses | |
| KR20170048206A (ko) | XBP-1(X-box binding protein 1) 유전자를 이용한 소포체 스트레스 분석용 조성물 | |
| JPWO2018199136A1 (ja) | Ａｂｌ１ ｔ３１５ｉ変異の発現レベルの測定方法 | |
| KR101978612B1 (ko) | 수태능력 예측을 위한 전사체 바이오 마커 | |
| KR102194880B1 (ko) | 개의 당뇨 위험성 예측용 snp 마커 및 이를 이용한 예측 방법 | |
| CN104630362A (zh) | 一种精子细胞转录调控相关基因的基因检测方法 | |
| DE602004020603D1 (de) | Verfahren zum nachweis des gens einer mutante des pankreatischen insel-amyloidproteins sowie nukleinsäuresonde und kit dafür | |
| Class et al. | Patent application title: Detection and Monitoring of Macrocyclic Lactone Resistance in Nematodes Inventors: Roger Prichard (Sainte-Anne-De-Bellevue, CA) Ludmel Urdaneta-Marquez (Verdun, CA) Joseph Dent (Montreal, CA) | |
| RU2014119886A (ru) | Материалы и методы для обнаружения гена арилоксиалканоатдиоксигеназы (aad-12) в растениях |